2465. Open-label, Multicenter Phase II Study of Combination Therapy of Imatinib Mesylate and Mycophenolate Mofetil in pediatric patients with Steroid-Refractory Sclerotic/fibrotic Type Chronic Graft-versus-host disease.
Choi JY, Kim H, Baek HJ, Kook H, Lee JM, Kim BK, An HY, Hong KT, Shin HY, Kang HJ.
2464. Somatic uniparental disomy mitigates the most damaging EFL1 allele combination in Shwachman-Diamond syndrome.
Lee S, Shin CH, Lee J, Jeong SD, Hong CR, Kim JD, Kim AR, Pak B, Son S, Kokhan O, Yoo T, Ko JS, Sohn YB, Kim OH, Ko JM, Cho TJ, Wright NT, Seong JK, Jin SW, Kang HJ, Kim HH, Choi M.
2463. Intracerebral hemorrhage as a rare complication of imatinib in a Philadelphia chromosome positive acute lymphoblastic leukemia pediatric patient.
Choi S, Choi JY, Kim BK, Yul Ahn H, Hong KT, Cheon JE, Shin HY, Kang HJ.
2460. Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
Hye Eun Park # 1 2 , Seung-Yeon Yoo # 2 3 , Nam-Yun Cho 2 , Jeong Mo Bae 2 4 , Sae-Won Han 5 , Hye Seung Lee 4 , Kyu Joo Park 6 , Tae-You Kim 5 , Gyeong Hoon Kang 7 8
2458. Targeted next-generation sequencing-based detection of microsatellite instability in colorectal carcinomas
Yunbeom Lee 1 , Ji Ae Lee 2 3 , Hye Eun Park 2 , Hyojun Han 1 , Yuhnam Kim 1 , Jeong Mo Bae 2 4 , Jung Ho Kim 4 , Nam-Yun Cho 2 , Hwang-Phill Kim 5 , Tae-You Kim 5 6 , Gyeong Hoon Kang 2 3